02.22.24 -- Discover Partners Focused On Cell & Gene Therapy

Millipore CTDMO Services delivers expertise and flexible solutions for viral vector development and manufacturing to advance cell and gene therapies from preclinical through commercial production.

We set ambitious goals to provide competent capacity and capabilities, investing in, building and ultimately deploying best-in-class viral vector manufacturing platforms that incorporate cutting-edge technologies.

Learn more about a biotech company, with a recently approved gene therapy product, that partnered with West to select a packaging solution that would allow them to meet their needs for storage at low temperatures and still get to market quickly.

Our expertise and capabilities allowed us to produce our own HEK293 production cell lines utilizing a wide variety of upstream platforms including iCellis, Cell Stacks, Univercells, and Stirred-Tank Reactors.

As a CDMO Partner for Life, our goal is to advance your cell therapies from lab to commercial scale, leveraging our cell and gene therapy expertise and global cGMP network.

Explore specificities and challenges, leveraging automation for scalability with the Cocoon Platform, and building a vein-to-vein network to achieve ‘just-in-time’ delivery of therapies.

PNI’s NanoAssemblr® microfluidic instruments, GenVoy™ lipid nanoparticle delivery reagents, and Biopharmaceutical Services enable researchers to translate disease biology insights into non-viral genomic medicines.

We are your life science solutions partner who ensures you have the right end-to-end solutions to address challenges in early development, commercialization, and post-market for your combination products, biologics, and medical devices.